Your browser doesn't support javascript.
loading
Collapse of the tumor stroma is triggered by IL-12 induction of Fas.
Kerkar, Sid P; Leonardi, Anthony J; van Panhuys, Nicolas; Zhang, Ling; Yu, Zhiya; Crompton, Joseph G; Pan, Jenny H; Palmer, Douglas C; Morgan, Richard A; Rosenberg, Steven A; Restifo, Nicholas P.
Afiliação
  • Kerkar SP; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Mol Ther ; 21(7): 1369-77, 2013 Jul.
Article em En | MEDLINE | ID: mdl-23568260
ABSTRACT
Engineering CD8⁺ T cells to deliver interleukin 12 (IL-12) to the tumor site can lead to striking improvements in the ability of adoptively transferred T cells to induce the regression of established murine cancers. We have recently shown that IL-12 triggers an acute inflammatory environment that reverses dysfunctional antigen presentation by myeloid-derived cells within tumors and leads to an increase in the infiltration of adoptively transferred antigen-specific CD8⁺ T cells. Here, we find that local delivery of IL-12 increased the expression of Fas within tumor-infiltrating macrophages, dendritic cells, and myeloid-derived suppressor cells (MDSC), and that these changes were abrogated in mice deficient in IL-12-receptor signaling. Importantly, upregulation of Fas in host mice played a critical role in the proliferation and antitumor activity of adoptively transferred IL-12-modified CD8⁺ T cells. We also observed higher percentages of myeloid-derived cell populations within tumors in Fas-deficient mice, indicating that tumor stromal destruction was dependent on the Fas death receptor. Taken together, these results describe the likely requirement for costimulatory reverse signaling through Fasl on T cells that successfully infiltrate tumors, a mechanism triggered by the induction of Fas expression on myeloid-derived cells by IL-12 and the subsequent collapse of the tumor stroma.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Interleucina-12 / Receptor fas Limite: Animals Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Interleucina-12 / Receptor fas Limite: Animals Idioma: En Ano de publicação: 2013 Tipo de documento: Article